Investigative Journalist Katherine Eban Exposes Massive Fraud at Generic Lipitor Manufacturer

The extent of the fraud astonished me. The company manipulated, and outright invented, testing data to win approval from regulators throughout the world. It ended up selling largely untested and unstable drugs in more than 40 countries. This was not simply cutting corners or engaging in lax manufacturing practices. It was outright fraud. The company knowingly sold substandard drugs while working to deceive regulators.